Hubrecht Organoid Technology and CrownBio announce a strategic partnership

(Hubrecht Organoid Technology) As part of the agreement CrownBio, a wholly-owned subsidiary of JSR Corporation, will expand its European presence by opening a new organoid-focused operational site in Utrecht, Netherlands. " We are delighted to increase access to HUB organoid technology for researchers worldwide through CrownBio's global reach and preclinical service expertise, " said Dr. Robert Vries, Executive Director of HUB. " This agreement is a pivotal moment in our growth and the evolution of the company, " said Dr. Jean-Pierre Wery, CEO of CrownBio.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news